AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹11 Cr | ₹12 Cr | ₹4.73 Cr | ₹5.35 Cr | ₹4.81 Cr |
What is the latest Total Non-Current Liabilities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹12 Cr |
Mar2022 | ₹4.73 Cr |
Mar2021 | ₹5.35 Cr |
Mar2020 | ₹4.81 Cr |
How is Total Non-Current Liabilities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | -9.79 | |
Mar2023 | ₹12 Cr | 152.61 | |
Mar2022 | ₹4.73 Cr | -11.63 | |
Mar2021 | ₹5.35 Cr | 11.14 | |
Mar2020 | ₹4.81 Cr | - |
Compare Total Non-Current Liabilities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹387.5 Cr | 2.5% | -9.6% | -18.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | 2.5% |
-9.6% |
-18.3% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses